Mary Barton, MD, MPP Vice President, Performance Measures “Balancing scientific and social dimensions of guidelines”

Slides:



Advertisements
Similar presentations
Culturally and Linguistically Appropriate Services And Clinical Trials (EDICTs CLAS-ACT) Armin D Weinberg Baylor College of Medicine.
Advertisements

1 Understanding How the U.S. Preventive Services Task Force Works USPSTF 101.
Tufts-New England Medical Center Evidence-based Practice Center Boston, MA Joseph Lau, MD, Director Ethan Balk, MD, MPH, Associate Director Thomas Trikalinos,
Study Objectives and Questions for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Participation Requirements for a Patient Representative.
Introduction to the User’s Guide for Developing a Protocol for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research.
Agency for Healthcare Research and Quality (AHRQ) Phillip Fitzsimmons and Dale Evans Government Documents Al Harris Library SWOSU.
Standards and Guidelines in EU countries EQUS Conference, Brussels, 2011 Roland Simon, Marica Ferri, EMCDDA.
Knowing What Works in Health Care : A Roadmap for the Nation Alliance for Health Reform April 4, 2008 Wilhelmine Miller, MS, PhD GWU SPHHS.
Comments on United States Preventive Services Task Force Draft Hepatitis C Screening Guideline Brian R. Edlin, MD, FACP, FIDSA Senior Principal Investigator.
HOW EVIDENCE AND EVIDENCE-BASED CLINICAL GUIDELINES HELP CAREGIVERS SUPPORT TREATMENT "Do Carers Care About Research? Laura (Collins) Lyster-Mensh, Executive.
1 The U.S. Preventive Services Task Force: The Challenge of Transparency Dr. Albert Siu New York Academy of Medicine.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Sue Sheridan, Acting Director, Patient.
RTI-UNC EPC Issues Exploration Forum (IEF):. Serious Mental Illness Dan Jonas, MD, MPH.
Clinical Policy / Practice Guideline Development Andy Jagoda, MD, FACEP Professor of Emergency Medicine Mount Sinai School of Medicine New York, New York.
Summarizing Community-Based Participatory Research: Background and Context for the Review Lucille Webb, MEd Eugenia Eng, DrPH Alice Ammerman, DrPH Meera.
Tobacco Cessation and Private Insurance under ACA: New Opportunities for Public Health September 25, 2014.
Systematic Reviews and the American Academy of Pediatrics Virginia A. Moyer, MD, MPH Professor of Pediatrics Baylor College of Medicine.
Chapter 7. Getting Closer: Grading the Literature and Evaluating the Strength of the Evidence.
Acute Ischemic Stroke Management: 2004 Emergency Medicine Perspectives.
Topic Generation and Research Prioritization Joe V. Selby, MD, MPH, Executive Director Rachael Fleurence, PhD, Scientist Rick Kuntz, MD, MSc, Chair, PDC.
Evidence Based Medicine (EBM) and Evidence Based Practice (EBP) in CSD.
How to Overcome Barriers and Develop Collaborative Guidelines Amir Qaseem, MD, PhD, MHA, FACP Chair, Guidelines International Network Director, Clinical.
Improving Preventive Health Care for Older Americans Marcel Salive, MD, MPH, FACPM Division of Geriatrics and Clinical Gerontology, NIA.
Stakeholder Engagement and Transparency in The Effective Health Care Program Supriya Janakiraman MD MPH AHRQ.
Patients at the Center: Guidelines for Effectiveness Carolyn M. Clancy, MD Director Agency for Healthcare Research and Quality New York Academy of Medicine.
Engaging Stakeholders in the Effective Health Care Program Information and tools for researchers and investigators.
Implementation Science and the Adoption of Practice in Addiction Treatment Harold I Perl, PhD Center for the Clinical Trials Network National Institute.
Revision Process for the PHS Guideline for Reducing HIV, HBV and HCV Transmission through Solid Organ Transplantation Matthew J. Kuehnert, M.D. Office.
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
Delmar Learning Copyright © 2003 Delmar Learning, a Thomson Learning company Nursing Leadership & Management Patricia Kelly-Heidenthal
Margo Michaels, MPH Executive Director, ENACCT Co PI, Communities as Partners in Cancer Clinical Trials, R13-HS Panel on Use and Implementation of.
Finding Relevant Evidence
HW215: Models of Health & Wellness Unit 7: Health and Wellness Models Geo-political Influences.
TEACH: LEVEL II – CLINICAL POLICIES AND GUIDELINES STREAM TEACH Plenary NYAM August 8 th, 2012 Craig A Umscheid, MD, MSCE, FACP Assistant Professor of.
TEACH LEVEL II: CLINICAL POLICIES AND GUIDELINES STREAM Craig A Umscheid, MD, MSCE, FACP Assistant Professor of Medicine and Epidemiology Director, Center.
Advancing Excellence in Health Care Perinatal Depression: Prevalence, Screening, Accuracy and Screening Outcomes Susan F. Meikle, M.D., M.S.P.H. Senior.
“Reaching across Arizona to provide comprehensive quality health care for those in need” AHCCCS/ADHS Report Summary & Recommendations.
Ann Bonham, PhD Chief Scientific Officer August 24, 2012 Methods, Metrics and Outcomes Evaluating the Success of Community Engaged Research.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
Lawrence B. Sadwin Friends of the World Heart Federation Foundation Moving Ahead: Leveraging Knowledge & Action to Improve Healthcare Quality. AHRQ 2012.
Introduction to Healthcare and Public Health in the US The Evolution and Reform of Healthcare in the US Lecture b This material (Comp1_Unit9b) was developed.
Systematic Reviews and American College of Physicians Clinical Practice Guidelines Amir Qaseem, MD, PhD, MHA, FACP Director, Clinical Policy American College.
Expanding the Capacity for Comparative Effectiveness Research
Panel Discussion USPSTF Recommendations: Process and Impact on Real-World Provision of Care John Santa MD MPH Director, Health Ratings Center Consumers.
THE IOWA MODEL OF EVIDENCE-BASED PRACTICE TO PROMOTE QUALITY CARE Jill Collins, Jerilyn Rodgers, Sandy Siebert & Julie Unruh **please refer to page 252.
Assembling a Systematic Review Team: Balancing Expertise and Potential Conflicts of Interest Avoiding bias in systematic reviews AHRQ annual meeting Bethesda.
Amir Qaseem, MD, PhD, MHA, FACP American College of Physicians May 11, 2011.
Using Simulation and Decision Modeling to Inform Decision Making AHRQ Annual Meeting Sept. 8, 2008.
Primary Care Improvement Infrastructure: The Role of Practice Facilitation Michael L. Parchman, MD MPH MacColl Center for Health Care Innovation AHRQ Annual.
EVIDENCE BASED PRACTICE CENTER Melissa McPheeters, PhD Co-Director, Vanderbilt EPC Engaging Stakeholders in EPC Work.
Stakeholder Engagement for Patient-Centered Outcomes Research Vanessa Jacoby, MD, MAS Associate Professor Obstetrics, Gynecology, and Reproductive Sciences.
The US Preventive Services Task Force: Potential Impact on Medicare Coverage Ned Calonge, MD, MPH Chair, USPSTF.
EVIDENCE-BASED MEDICINE AND PHARMACY 1. Evidence-based medicine 2. Evidence-based pharmacy.
H ⊕ lger Schünemann, MD, PhD Professor and Chair, Dept. of Clinical Epidemiology & Biostatistics Professor of Medicine Michael Gent Chair in Healthcare.
Workshop on Standards for Clinical Practice Guidelines Institute of Medicine January 11, 2010 Vivian H. Coates, Vice President, ECRI Project Director,
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
Evidence-Based Mental Health PSYC 377. Structure of the Presentation 1. Describe EBP issues 2. Categorize EBP issues 3. Assess the quality of ‘evidence’
Ghada Aboheimed, Msc. Review the principles of an evidence based approach to clinical practice. Appreciate the value of EBM Describe the 5 steps of evidence.
Presentation Developed for the Academy of Managed Care Pharmacy
US Preventive Services Task Force :
Quality Health Care Nursing 870
Systematic Reviews and Medical Policy Determinations
Presentation Developed for the Academy of Managed Care Pharmacy
PCORI Research Priorities and Relevant Examples
Using Evidence For Better Health Policy
Component 1: Introduction to Health Care and Public Health in the U.S.
Evidence-Based Public Health
Presentation Developed for the Academy of Managed Care Pharmacy
Presentation transcript:

Mary Barton, MD, MPP Vice President, Performance Measures “Balancing scientific and social dimensions of guidelines”

2 US Preventive Services Task Force Established 1984 for initial five year project Panel of Non-Federal experts Since 1990 supported by the Agency for Healthcare Research and Quality AHRQ’s predecessor agency in hot water from “Guidelines” USPSTF makes “Recommendations”

3 USPSTF: Simplified M.O. Since 1990, increasing bar of evidence requirements Review of literature Systematic Evidence Review – Key Questions established from the start – Analytic Framework – Exhaustive and complete review of published literature

4 USPSTF: Simplified M.O. Assessment of literature shared between – Evidence review team Quality Eye toward resistance to bias – USPSTF Relevance, applicability Where is it justifiable to extrapolate?

5 USPSTF: Simplified M.O. Not surprised by controversy – Breast Cancer has historically stirred wide, sometimes acrimonious debate – 2002 USPSTF review and recommendation – 1997 NIH Consensus Conference Majority and Minority Statements

6 Policy Advances 2003 Medicare Modernization Act – Evidence-based Practice Center program 2008 Medicare Improvement for Patients and Providers (MIPPA) – Authority for Sec’y HHS to generate Medicare Coverage Decisions Debate around the Affordable Care Act

7 Helpful principles Communicate early, often, and frequently Increase points of engagement Seek public and patient voices

8 New M.O. for USPSTF At start of review process – Post Analytic Framework and Key Questions for Public Comment In review of EPC reports – Seek diverse opinions for formal review Draft form of Recommendations – Posting all Task Force Recommendations as Drafts for Public Comment – Now ~18 months into trial Variety of stakeholder engagements

9 Current tension “The efforts by politicians to reject the committee's scientific findings have been condemned as an example of unwarranted political interference in scientific research.” [ Wikipedia ]political interference in scientific research The Value of Including Patient Voices – AHRQ’s Comparative Effectiveness program work on methods for increasing public involvement – Institute of Medicine report on Trustworthy Clinical Practice Guidelines

10 Discussion Points As scientific research is gathered into Reviews Policy Statements Clinical guidelines or Recommendations Performance Measures Seek out meaningful public input Establish effective routes of communication with key stakeholders